Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors.

Abstract

BACKGROUND:

Proton pump inhibitors (PPIs) have been recognized as a primary treatment of eosinophilic esophagitis (EoE), an allergic inflammatory disease of the esophageal mucosa. The mechanisms underlying esophageal epithelial responses to PPIs remain poorly understood.

OBJECTIVE:

We hypothesized that PPIs can counteract IL-13-mediated esophageal epithelial responses that are germane for EoE pathogenesis.

METHODS:

Transcriptional responses of human esophageal cells to IL-13 and the PPIs omeprazole and esomeprazole were assessed by RT-PCR and RNA sequencing. Cytokine secretion was measured by multiplex analysis and ELISA.

RESULTS:

Human esophageal epithelial cells robustly responded to PPI stimulation by inducing a set of 479 core genes common between omeprazole and esomeprazole treatments. The transcriptional response to PPIs was partially mediated through the aryl hydrocarbon receptor signaling pathway, as the aryl hydrocarbon receptor antagonist GNF-351 modified approximately 200 genes, particularly those enriched in metabolic processes and regulation of cell death. PPI treatment reversed approximately 20% of the IL-13 transcriptome. Functional analysis of the PPI-responsive, upregulated genes revealed enrichment in metabolic and oxidation processes, and the unfolded protein response. In contrast, downregulated genes were overrepresented in functional terms related to cell division and cytoskeletal organization, which were also enriched for the genes in the EoE transcriptome reversed by PPIs. Furthermore, PPI treatment decreased the IL-13-induced proliferative response of esophageal epithelial cells.

CONCLUSIONS:

These results demonstrate broad effects of PPIs on esophageal epithelium, including their ability to curtail transcriptomic processes involved in cellular proliferation and IL-13-induced responses, and they highlight the importance of AHR signaling in mediating these responses.

• Authors: Mark Rochman, Yong Mei Xie, Lydia Mack, Julie M Caldwell, Andrea M Klingler, Garrett A Osswald, Nurit P Azouz, Marc E Rothenberg
• Journal: The Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 147 Issue 5 Pg. 1924-1935 (05 2021) ISSN: 1097-6825 [Electronic] United States
• PMID: 33289661 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Chemical References

• Interleukin-13
• Proton Pump Inhibitors
• Receptors, Aryl Hydrocarbon
• Omeprazole

Topics

• Animals
• Cell Line
• Eosinophilic Esophagitis (genetics, immunology)
• Epithelial Cells (drug effects, immunology)
• Esophageal Mucosa (cytology)
• Humans
• Interleukin-13 (immunology)
• Mice
• Omeprazole (pharmacology)
• Proton Pump Inhibitors (pharmacology)
• Receptors, Aryl Hydrocarbon (immunology)
• Transcription, Genetic (drug effects)